298 related articles for article (PubMed ID: 25026296)
1. MicroRNA-25 regulates chemoresistance-associated autophagy in breast cancer cells, a process modulated by the natural autophagy inducer isoliquiritigenin.
Wang Z; Wang N; Liu P; Chen Q; Situ H; Xie T; Zhang J; Peng C; Lin Y; Chen J
Oncotarget; 2014 Aug; 5(16):7013-26. PubMed ID: 25026296
[TBL] [Abstract][Full Text] [Related]
2. Dietary compound isoliquiritigenin targets GRP78 to chemosensitize breast cancer stem cells via β-catenin/ABCG2 signaling.
Wang N; Wang Z; Peng C; You J; Shen J; Han S; Chen J
Carcinogenesis; 2014 Nov; 35(11):2544-54. PubMed ID: 25194164
[TBL] [Abstract][Full Text] [Related]
3. Dietary compound isoliquiritigenin inhibits breast cancer neoangiogenesis via VEGF/VEGFR-2 signaling pathway.
Wang Z; Wang N; Han S; Wang D; Mo S; Yu L; Huang H; Tsui K; Shen J; Chen J
PLoS One; 2013; 8(7):e68566. PubMed ID: 23861918
[TBL] [Abstract][Full Text] [Related]
4. MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2).
Jiao X; Zhao L; Ma M; Bai X; He M; Yan Y; Wang Y; Chen Q; Zhao X; Zhou M; Cui Z; Zheng Z; Wang E; Wei M
Breast Cancer Res Treat; 2013 Jun; 139(3):717-30. PubMed ID: 23780685
[TBL] [Abstract][Full Text] [Related]
5. Autophagy, Cell Viability, and Chemoresistance Are Regulated By miR-489 in Breast Cancer.
Soni M; Patel Y; Markoutsa E; Jie C; Liu S; Xu P; Chen H
Mol Cancer Res; 2018 Sep; 16(9):1348-1360. PubMed ID: 29784669
[TBL] [Abstract][Full Text] [Related]
6. The microRNA miR-181c enhances chemosensitivity and reduces chemoresistance in breast cancer cells via down-regulating osteopontin.
Han B; Huang J; Han Y; Hao J; Wu X; Song H; Chen X; Shen Q; Dong X; Pang H; Cai L
Int J Biol Macromol; 2019 Mar; 125():544-556. PubMed ID: 30537505
[TBL] [Abstract][Full Text] [Related]
7. Isoliquiritigenin induces apoptosis and autophagy and inhibits endometrial cancer growth in mice.
Wu CH; Chen HY; Wang CW; Shieh TM; Huang TC; Lin LC; Wang KL; Hsia SM
Oncotarget; 2016 Nov; 7(45):73432-73447. PubMed ID: 27708238
[TBL] [Abstract][Full Text] [Related]
8. MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy.
Jin F; Wang Y; Li M; Zhu Y; Liang H; Wang C; Wang F; Zhang CY; Zen K; Li L
Cell Death Dis; 2017 Jan; 8(1):e2540. PubMed ID: 28079894
[TBL] [Abstract][Full Text] [Related]
9. Isoliquiritigenin suppresses human melanoma growth by targeting miR-301b/LRIG1 signaling.
Xiang S; Chen H; Luo X; An B; Wu W; Cao S; Ruan S; Wang Z; Weng L; Zhu H; Liu Q
J Exp Clin Cancer Res; 2018 Aug; 37(1):184. PubMed ID: 30081934
[TBL] [Abstract][Full Text] [Related]
10. Mammalian target of rapamycin regulates isoliquiritigenin-induced autophagic and apoptotic cell death in adenoid cystic carcinoma cells.
Chen G; Hu X; Zhang W; Xu N; Wang FQ; Jia J; Zhang WF; Sun ZJ; Zhao YF
Apoptosis; 2012 Jan; 17(1):90-101. PubMed ID: 21956714
[TBL] [Abstract][Full Text] [Related]
11. Psammaplin A induces Sirtuin 1-dependent autophagic cell death in doxorubicin-resistant MCF-7/adr human breast cancer cells and xenografts.
Kim TH; Kim HS; Kang YJ; Yoon S; Lee J; Choi WS; Jung JH; Kim HS
Biochim Biophys Acta; 2015 Feb; 1850(2):401-10. PubMed ID: 25445714
[TBL] [Abstract][Full Text] [Related]
12. miR-485-5p suppresses breast cancer progression and chemosensitivity by targeting survivin.
Wang M; Cai WR; Meng R; Chi JR; Li YR; Chen AX; Yu Y; Cao XC
Biochem Biophys Res Commun; 2018 Jun; 501(1):48-54. PubMed ID: 29678577
[TBL] [Abstract][Full Text] [Related]
13. A new synthetic HDAC inhibitor, MHY218, induces apoptosis or autophagy-related cell death in tamoxifen-resistant MCF-7 breast cancer cells.
Park JH; Ahn MY; Kim TH; Yoon S; Kang KW; Lee J; Moon HR; Jung JH; Chung HY; Kim HS
Invest New Drugs; 2012 Oct; 30(5):1887-98. PubMed ID: 21983700
[TBL] [Abstract][Full Text] [Related]
14. Isoliquiritigenin inhibits pancreatic cancer progression through blockade of p38 MAPK-regulated autophagy.
Zhang Z; Chen WQ; Zhang SQ; Bai JX; Liu B; Yung KK; Ko JK
Phytomedicine; 2022 Nov; 106():154406. PubMed ID: 36029643
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway.
Shen H; Li L; Yang S; Wang D; Zhong S; Zhao J; Tang J
Gene; 2016 Nov; 593(1):84-90. PubMed ID: 27523474
[TBL] [Abstract][Full Text] [Related]
16. Anti-osteoclastogenic activity of isoliquiritigenin via inhibition of NF-κB-dependent autophagic pathway.
Liu S; Zhu L; Zhang J; Yu J; Cheng X; Peng B
Biochem Pharmacol; 2016 Apr; 106():82-93. PubMed ID: 26947453
[TBL] [Abstract][Full Text] [Related]
17. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Qiu Y; Yagüe E; Ji W; Liu J; Zhang J
Cell Death Dis; 2016 Jun; 7(6):e2291. PubMed ID: 27362808
[TBL] [Abstract][Full Text] [Related]
18. Silencing of MicroRNA-21 confers the sensitivity to tamoxifen and fulvestrant by enhancing autophagic cell death through inhibition of the PI3K-AKT-mTOR pathway in breast cancer cells.
Yu X; Li R; Shi W; Jiang T; Wang Y; Li C; Qu X
Biomed Pharmacother; 2016 Feb; 77():37-44. PubMed ID: 26796263
[TBL] [Abstract][Full Text] [Related]
19. MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.
Zhong S; Li W; Chen Z; Xu J; Zhao J
Gene; 2013 Nov; 531(1):8-14. PubMed ID: 23994196
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway.
Miao Y; Zheng W; Li N; Su Z; Zhao L; Zhou H; Jia L
Sci Rep; 2017 Feb; 7():41942. PubMed ID: 28165066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
